Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

California employees looking for a better deal in union negotiations as the company posts record profits

Anti-masker abuse, subpar healthcare, and a 5 cent raise: CVS workers say enough is enough

Kraft Heinz

Got $5,000? These 2 Value Stocks Could Be Hot Buys for 2022

AbbVie

Caterpillar

Citizens & Northern

Deere & Company

Diversified Healthcare Trust

Eaton

General Dynamics

General Mills

Hormel Foods

Heritage Commerce

Illinois Tool Works

Kinder Morgan

National Grid

Norfolk Southern

Norwood Financial

Realty Income Corp

Orrstown Financial

People's United Financial

Healthpeak Properties

Provident Financial Services

Procter & Gamble

Reynolds Consumer Products

Sabra Health Care

In August, my wife and I received a total of $1,307.71 of dividend income. We crossed one thousand dollars again in an off-month. Another strong month of dividend income, and the 4-digit mark is becoming more and more consistent. Despite the pandemic from COVID-19, dividend income continues to grow, due primarily to additional investment and reinvestment. During the month of August, my wife and I actually invested over $4,500+ into dividend-producing stocks!

Dividend Income Summary: Lanny's August 2021 Summary

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

CVS Health (CVS) Up 8.6% Since Last Earnings Report: Can It Continue?

Albertsons Companies

Agree Realty

American Fin Tr Inc - Ordinary Shares - Class A

American Fin Tr Inc - 7.50% PRF PERPETUAL USD 25 - Ser A

Acadia Realty Trust

Amazon

Alpine Global Premier Properties Fund

Bed Bath & Beyond

Best Buy

Saul Centers

Cambria Global Real Estate ETF

Broadstone Net Lease

Brookfield Property REIT

Brixmor Property Group

CBL & Associates Properties

Cedar Realty Trust

Costco

CoStar Group

DoorDash

Dick's Sporting Goods

WisdomTree Global ex-US Real Estate Fund

EPR Properties

Essential Properties Realty Trust Inc

Big Box Is Back: The COVID pandemic has radically transformed consumer spending habits - perhaps permanently - shifting spending towards goods over services and towards larger-format retailers over smaller shops. While enclosed regional malls face a long and uncertain road to recovery, the outlook for open-air Shopping Center REITs has brightened considerably this year. Recent earnings results have been impressive.

Shopping Center REITs: Big Box Boom

QuidelOrtho Corp

Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across the U.S. and online at cvs.com. CVS Pharmacy is a part of CVS Health Corp (NYSE: CVS).

Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy

Walgreens

Benzinga's weekly Stock Wars matches up two leaders in a major industry sector, with the goal of determining which company is the better investment. This week, the duel is between a pair of pharmacy retail chains: CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA).

Stock Wars: CVS Health Vs. Walgreens Boots Alliance

WOONSOCKET, R.I. , Sept. 1, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S.

CVS Health to Present at the 19th Annual Morgan Stanley Global Healthcare Conference

The delta variant has people rushing to get in line, and not just for a third wave of shots.

These 2 Pharmacy Chains Will Benefit From COVID Vaccine Boosters

Just like other goods and services, consumers also want convenient and efficient access to a range of healthcare choices and CVS is the latest entrant trying to meet this changing need. For all the well-documented fatalities and respiratory ravages that COVID-19 has inflicted, the virus has also unleashed a lesser-known torrent of mental health issues.

COVID-Related Stress and Rising Demand See CVS Expand into Mental Health Counseling

WOONSOCKET, R.I., Aug. 30, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it has opened the first MinuteClinic locations in Washington.

CVS Health Opens First MinuteClinic Locations in Washington as part of Nationwide Expansion of CVS HealthHUB™ Locations

Cummins

Insight Enterprises

Q2'21 earnings reveal these three Long Ideas continue to have strong upside potential. Insight Enterprises' combination of strong business relationships, quality customer service, knowledgeable consultants, and integration of hardware and software solutions, creates an offering that adds value to both customers and shareholders.

Insight Enterprises, Cummins, And CVS Health Will Keep Creating Shareholder Value After Q2'21

CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The limits apply to Abbott Laboratories' (NYSE: ABT) BinaxNOW along with a test from Ellume, according to an email from a CVS spokesperson, Bloomberg reported.

See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests

CVS Health trades for around 10x 2022 earnings estimates and even less when valued against free cash flow, but Wall Street is ignoring it in favor of high-flying tech names. CVS is using earnings to pay down debt, but soon should be able to put through a dividend hike and buyback program.

Can CVS Stock Reach $100? Pounding The Table On My Top 2021 Pick

2Q21 earnings reveal these three Long Ideas continue to have strong upside potential.

Insight Enterprises, Cummins, And CVS Health Corp Will Keep Creating Shareholder Value After 2Q21

WOONSOCKET, R.I., Aug. 23, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the Reference Yield and Total Consideration (each as summarized in the table below) to be paid in connection with the previously announced cash tender offer (the "Tender Offer") for up to $2,049,919,000 principal amount (the "Maximum Amount"), of its 4.300% Senior Notes due 2028 (the "Notes").

CVS Health Corporation Announces Pricing of Tender Offer

WOONSOCKET, R.I., Aug. 23, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the early results of the previously announced cash tender offer (the "Tender Offer") and that it is amending the Tender Offer by increasing the aggregate principal amount to $2,049,919,000 (as increased and amended, the "Maximum Amount") from $2,000,000,000, of its 4.300% Senior Notes due 2028 (the "Notes").

CVS Health Corporation Announces Early Results and Upsize of Previously Announced Cash Tender Offer to an Aggregate Principal Amount of $2,049,919,000 from $2,000,000,000

WOONSOCKET, R.I., Aug. 18, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) is reminding Americans that as the country continues to deal with the impact of the COVID-19 pandemic it is more important than ever to stay current with vaccinations and other routine health care needs.

Flu Shots Now Available at CVS Pharmacy® and MinuteClinic®

CVS Health Corporation represents an investment with a high degree of uncertainty. CVS just closed 2020 on a disappointing note and is likely to continue to be pressured on multiple fronts in the near future.

CVS Health Corporation - Good Setup For Long Call Option Play

WOONSOCKET, R.I., Aug. 10, 2021 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced an innovative health care solution, Aetna Virtual Primary Care, that reimagines the primary care experience and makes it easier for people to get the health services they need, anytime, anywhere.

CVS Health launches first nationwide virtual primary care solution

News for CVS Health Stock (CVS)